Search Results - "Jaglal, Michael"

Refine Results
  1. 1

    The Efficacy and Safety of Rivaroxaban and Dalteparin in the Treatment of Cancer Associated Venous Thrombosis by Chaudhury, Ateefa, Balakrishnan, Asha, Thai, Christy, Holmstrom, Bjorn, Nanjappa, Sowmya, Ma, Zhenjun, Jaglal, Michael V.

    “…Venous thromboembolism (VTE) is a complication of malignancy that is associated with significant mortality. The CLOT trial showed superiority of dalteparin in…”
    Get full text
    Journal Article
  2. 2

    A phase I/II study of docetaxel in combination with pegylated liposomal doxorubicin in metastatic castration-resistant prostate cancer by Laber, Damian A., Eatrides, Jennifer, Jaglal, Michael V., Haider, Mintallah, Visweshwar, Nathan, Patel, Ankita

    “…Taxanes and anthracyclines have been among the best-studied chemotherapy classes in castration-resistant prostate cancer (CRPC). Docetaxel (D) 75 mg/m 2 every…”
    Get full text
    Journal Article
  3. 3

    Plasma of Acute Lymphoblastic Leukemia Patients React to the Culture of a Mycovirus Containing Aspergillus flavus by Tebbi, Cameron K, Badiga, Aruna, Sahakian, Eva, Arora, Anshul I, Nair, Sajitha, Powers, John J, Achille, Alex N, Jaglal, Michael V, Patel, Saumil, Migone, Felicia

    Published in Journal of pediatric hematology/oncology (01-07-2020)
    “…Acute lymphoblastic leukemia (ALL) is the most common cancer in children and is also seen in adults. Currently, no plasma-based test for the detection of ALL…”
    Get full text
    Journal Article
  4. 4

    Clinicopathologic characteristics and outcomes of histiocytic and dendritic cell neoplasms: the moffitt cancer center experience over the last twenty five years by Dalia, Samir, Jaglal, Michael, Chervenick, Paul, Cualing, Hernani, Sokol, Lubomir

    Published in Cancers (14-11-2014)
    “…Neoplasms of histiocytic and dendritic cells are rare disorders of the lymph node and soft tissues. Because of this rarity, the corresponding biology,…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Manifestations of gastrointestinal plasmablastic lymphoma: A case series with literature review by Luria, Lynette, Nguyen, Johnny, Zhou, Jun, Jaglal, Michael, Sokol, Lubomir, Messina, Jane L, Coppola, Domenico, Zhang, Ling

    Published in World journal of gastroenterology : WJG (07-09-2014)
    “…Plasmablastic lymphoma(PBL) rarely occurs in the gastrointestinal(GI) tract with limited studies reported. We reviewed the clinical histories and pathology of…”
    Get full text
    Journal Article
  8. 8
  9. 9

    First description of atrial fibrillation and congenital thrombotic thrombocytopenic purpura treated by left atrial appendage occlusion by Basrawala, Hussain, Finley, Katherine, Jaglal, Michael, Mohanty, Bibhu D.

    Published in EJHaem (01-05-2023)
    “…Given an increased risk of both thrombosis and bleeding, thrombotic thrombocytopenic purpura (TTP) presents a unique challenge when anticoagulation is required…”
    Get full text
    Journal Article
  10. 10

    Cladribine, cytarabine, filgrastim, and mitoxantrone (CLAG-M) compared to standard induction in acute myeloid leukemia from myelodysplastic syndrome after azanucleoside failure by Jaglal, Michael V, Duong, Vu H, Bello, Celeste M, Al Ali, Najla H, Padron, Eric, Fernandez, Hugo F, List, Alan F, Lancet, Jeffrey E, Komrokji, Rami S

    Published in Leukemia research (01-04-2014)
    “…Abstract For patients with acute myeloid leukemia from antecedent myelodysplastic syndrome particularly after azanucleoside treatment failure, outcome is poor…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Phase II pilot study of oral dasatinib in patients with higher-risk myelodysplastic syndrome (MDS) who failed conventional therapy by Duong, Vu H, Jaglal, Michael V, Zhang, Ling, Kale, Vishakha, Lancet, Jeffrey E, Komrokji, Rami S, List, Alan F

    Published in Leukemia research (01-03-2013)
    “…Abstract Given evidence for the role of Src family kinases, especially Lyn kinase, in myeloblast proliferation and the in vitro inhibitory activity of…”
    Get full text
    Journal Article
  13. 13

    Human papillomavirus in metastatic squamous carcinoma from unknown primaries in the head and neck: A retrospective 7 year study by Desai, Payal C., Jaglal, Michael V., Gopal, Purva, Ghim, Shin-Je, Miller, Donald M., Farghaly, Hanan, Jenson, Alfred B.

    Published in Experimental and molecular pathology (01-10-2009)
    “…Goal: Human Papillomavirus (HPV) is found to be increasingly implicated in head and neck cancers. The objective of this study was to determine the primary site…”
    Get full text
    Journal Article
  14. 14

    Primary B-cell CNS lymphoma clinicopathologic and treatment outcomes in 89 patients from a single tertiary care center by Dalia, Samir, Forsyth, Peter, Chavez, Julio, Price, Samantha, Shah, Bijal, Bello, Celeste, Sokol, Lubomir, Pan, Edward, Sotomayor, Eduardo, Lee, Ji-Hyun, Fisher, Kate, Jaglal, Michael

    Published in International journal of hematology (01-04-2014)
    “…Primary central nervous system lymphoma (PCNSL) is a rare aggressive variant of diffuse large B-cell lymphoma with a poor prognosis and no defined optimal…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Efficacy and safety of direct oral anticoagulants (DOACs) and low molecular weight heparin (LMWH) for primary prevention of venous thromboembolism (VTE) in ambulatory cancer patients by Shenouda, Mina, Desai, Ruchi, Jaglal, Michael Vishal

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only 12088 Background: Active malignancy is a well described risk factor for thrombosis. Randomized clinical trials (RCT) have evaluated…”
    Get full text
    Journal Article
  17. 17

    Obtaining routine blood cultures during interleukin-2-containing therapy is unnecessary by Jaglal, Michael V, Laber, Damian A, Arnold, Forest W, Miller, Donald M, Chesney, Jason A, Kloecker, Goetz H

    Published in American journal of clinical oncology (01-08-2009)
    “…To evaluate the usefulness of routine blood cultures in patients who develop temperatures of 38.5 degrees C or higher while treated with interleukin-2 (IL-2)…”
    Get full text
    Journal Article
  18. 18

    Catheter Related Thrombosis (CRT) in Hematologic Malignancy: A Retrospective Study of Venous Thromboembolism Management by Desai, Ruchi, Tandon, Ankita, Jaglal, Michael

    Published in Blood (13-11-2019)
    “…Introduction: Central Venous Catheters (CVC) improve quality of life for patients with hematologic malignancy but long-term presence may result in CRT. Optimal…”
    Get full text
    Journal Article
  19. 19

    Risks and Outcomes of Tumor Lysis Syndrome in Patients Admitted with Diffuse Large B Cell Lymphoma; A Nationwide Analysis by Farooq, Muhammad, Ammad-ud-din, Muhammad, Shahzad, Moazzam, Jahan, Asmat, Jaglal, Michael V.

    Published in Blood (02-11-2023)
    “…Background: Tumor lysis syndrome (TLS) is a feared complication particularly among patients of diffuse large B cell lymphoma (DLBCL) with bulky…”
    Get full text
    Journal Article
  20. 20

    Unveiling Gender Disparities: Female Authorship in Pivotal Trials for US Food and Drug Administration (FDA)-Approved Novel Chimeric Antigen Receptor T-Cell Therapies by Farooq, Muhammad, Sohail, Aruba, Khan, Sara, Ukrani, Janta, Zahid, Ibrahim, Hassan, Maryum, Jaglal, Michael V.

    Published in Blood (02-11-2023)
    “…Introduction CAR-T cell therapy, an FDA-approved breakthrough in hematologic malignancy treatment, has emerged as a game-changer through rigorous pivotal…”
    Get full text
    Journal Article